|
显示项目 878296-878305 / 2346275 (共234628页)
<< < 87825 87826 87827 87828 87829 87830 87831 87832 87833 87834 > >>
每页显示[10|25|50]项目
| 中山醫學大學 |
2021 |
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
|
Nash, P; Mease, PJ; Fleishaker, D; Wu, J; Coates, LC; Behrens, F; Gladman, DD; Kivitz, AJ; Wei, JC; Shirinsky, I; Menon, S; Romero, AB; Fallon, L; Hsu, MA; Wang, CS; Kanik, KS |
| 中山醫學大學 |
2020 |
TOFACITINIB AS MONOTHERAPY FOLLOWING METHOTREXATE WITHDRAWAL IN PATIENTS WITH PSORIATIC ARTHRITIS PREVIOUSLY TREATED WITH OPEN-LABEL TOFACITINIB plus METHOTREXATE: A RANDOMISED, PLACEBO-CONTROLLED SUBSTUDY OF OPAL BALANCE
|
Nash, P; Coates, LC; Mease, PJ; Kivitz, A; Gladman, DD; Behrens, F; Wei, JCC; Fleishaker, D; Wu, J; Wang, C; Romero, AB; Fallon, L; Hsu, MA; Kanik, K |
| 臺大學術典藏 |
2021-02-02T02:47:53Z |
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four–Month, Phase III Study
|
van der Heijde D.; Strand V.; Tanaka Y.; Keystone E.; Kremer J.; Zerbini C.A.F.; Cardiel M.H.; Cohen S.; Nash P.; Song Y.-W.; Tegzová D.; Gruben D.; Wallenstein G.; Connell C.A.; Fleischmann R.; Hall S.; Nicholls D.; Rischmueller M.; Baker M.F.; Bessette L.; Cividino A.A.; Haraoui B.; Niall Jones H.; Keystone E.C.; Khraishi M.; Thorne J.; Birbara C.A.; Baraf H.S.B.; Bathon J.M.; Brodsky A.L.; Cush J.J.; Dikranian A.H.; Diri E.; Dura P.A.; Lohr K.M.; Fleischmann R.M.; Griffin R.M.; Halter D.G.; Hargrove J.K.; Bouda D.W.; Reddy Pasya S.K.; Hill G.L.; Jackson R.E.; Kafka S.P.; Kaine J.L.; Katzenstein P.L.; Kempf K.J.; Kolba K.S.; Kremer J.M.; Longley S.; Mathews S.D.; Milton A.C.; Misischia R.J.; Moorman H.A.; Moreland L.W.; Niemer M.W.; Palmer W.R.; Sayers M.E.; Schuette P.T.; Shamim T.; Shergy W.J.; Sikes D.H.; Silverfield J.C.; Siva C.; Taborn J.D.; Walsh B.T.; Wells A.F.; Wolfe S.M.; Adhikari P.; Amano K.; Bae S.-C.; Chandrashekara S.; Chopra A.K.; PING-NING HSU; Iwahashi M.; Kadel J.K.; Kawabe Y.; Koh E.-M.; Lan J.-L.; Lee S.-K.; Lin H.-Y.; Liou L.-B.; Liu M.-F.; Migita K.; Miyamoto T.; Miyasaka N.; Mori S.; Munakata Y.; Ohta S.; Park W.; Park S.-H.; Rao U.R.; Shim S.C.; Shobha V.; Takasaki Y.; Takeuchi T.; Tanaka Y.; Tohma S.; Tsai W.-C.; Ueki Y.; Veeravalli S.C.M.; Wagh S.; Yamanaka H.; Yoo B.; Batalov A.; Bichoversuska D.; Dvorak Z.; Goranov I.; Hrytsenko H.M.; Kopackova J.; Mosterova Z.; Oparanov B.; Petrov A.; Pokrzywnicka-Gajek I.; Povoroznyuk V.V.; Rosa J.; Ruzga Z.; Settas L.; Stanislavchuk M.A.; Tseluyko V.I.; Vitek P.; de Freitas Zerbini C.A.; Brenol J.C.T.; Cardiel-Rios M.H.; Escalante W.J.O.; Maldonado-Lopez M.C.; Jaller Raad J.J.; Hernandez J.D.M.; Jauregui E.A.; Keiserman M.W.; Melazzi A.C.C.; Pascual-Ramos V.; Pinto L.T.; Radominski S.C.; Ximenes A.C.; de Morales S.V.; the ORAL Scan Investigators |
| 臺大學術典藏 |
2019-02-13T05:12:56Z |
Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study
|
TSEN-FANG TSAI; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:45Z |
Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study
|
Gardner A.C.; Valdez H.; Tallman A.; Tan H.; Ports W.C.; Harper M.K.; TSEN-FANG TSAI; Valenzuela F.;Korman N.J.;Bissonnette R.;Bakos N.;Tsen-Fang Tsai;Harper M.K.;Ports W.C.;Tan H.;Tallman A.;Valdez H.;Gardner A.C.; Valenzuela F.; Korman N.J.; Bissonnette R.; Bakos N. |
| 臺大學術典藏 |
2017-10 |
Tofacitinib in psoriatic arthritis
|
TSEN-FANG TSAI; Ting-Shun Wang and Tsen-Fang Tsai |
| 臺大學術典藏 |
2020-10-22T07:27:48Z |
Tofacitinib in psoriatic arthritis
|
TSEN-FANG TSAI; Wang T.-S. |
| 臺大學術典藏 |
2021-02-02T02:47:53Z |
Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan
|
Chen D.-Y.; PING-NING HSU; Tang C.-H.; Claxton L.; Valluri S.; Gerber R.A. |
| 國立成功大學 |
2023 |
Tofacitinib treatment in anti-glycyl-tRNA synthetase antibody interstitial lung disease – A case report
|
Tseng, C.-W. |
| 臺大學術典藏 |
2018-09-10T15:28:29Z |
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Results from two randomized, placebo-controlled, phase III trials
|
Papp, K.A.;Menter, M.A.;Abe, M.;Elewski, B.;Feldman, S.R.;Gottlieb, A.B.;Langley, R.;Luger, T.;Thaci, D.;Buonanno, M.;Gupta, P.;Proulx, J.;Lan, S.;Wolk, R.; TSEN-FANG TSAI |
显示项目 878296-878305 / 2346275 (共234628页)
<< < 87825 87826 87827 87828 87829 87830 87831 87832 87833 87834 > >>
每页显示[10|25|50]项目
|
